Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-04

Clinical Trial Update: ABT-436 for Alcohol Dependence [Phase 2]

View source ↗

Summary

ABT-436 completed a Phase 2 trial for alcohol use disorder; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ABT-436

Snippet

Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Conditions: Alcohol Dependence, Alcohol Abuse | Phase 2 | Status: COMPLETED | Results posted: 2017-04-04